Webcast Auction
2-Day Webcast Auction Sale of Contract Pharmaceuticals Limited Niagara: April 18-19, Buffalo, NY, 500,000 Sq. Ft. Contract Processing & Packaging Facility.
2-Day Webcast Auction Sale of Contract Pharmaceuticals Limited Niagara - April 18 & 19, Buffalo, NY, 500,000 Sq. Ft. Contract Processing & Packaging Facility.
Complete Liquid & Semi-Solid Processing and Packaging Plant Including Multiple Stainless Steel Liquid Processing Rooms, (13) Turnkey Liquid Packaging Lines & (5) Metal and Hot Air Automatic Tube Filling Lines, High Speed Secondary Packaging & Labeling, Ingredient Weighing Department, Large Amount of QC and Pilot Lab Equipment, Facility Support & Warehouse Equipment with Bidding Onsite and Online - Over 2,000 Lots!
Features Items:Over 90 Stainless Steel Jacketed Process Tanks, Kettles, Silos and Storage Tanks:(13) Triple & Double Motion Hemispherical Bottom Jacketed Mixing Tanks and Kettles - 100 - 1,000 Gallon(80+) SS Jacketed Agitated Tanks and Kettles from 5 - 1,500 GallonOlsa Triple Motion Jacketed XP Vacuum Batch Processor - 4,000 Liter Lee Triple Motion Vacuum & Internal Pressure Rated KettlesFeldmeier, CB and Crepaco 5,000 - 15,000 Gallon SS Jacketed Agitated Silos and Storage Tanks, Resin Silos and Flammable Liquid Storage & Much More!
Sale Location: 100 Forest Avenue, Buffalo, NY 14212, Start time is 10:30am EST, Inspection: Apr. 17, 9am-4pm or by appointments only. Contact: ericw@newmillcapital.com. For complete information, go to www.newmillcapital.com or call 888-801-6032.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
